Heart disease
References
1 Bhatnagar, D., & P. Durrington. 2003. Omega-3 fatty acids: Their
role in the prevention and treatment of atherosclerosis related risk factors and
complications. Int. J. Clin. Pract., 57 (4), 305–314. Review.
deBree, A., et al. 2004. Evidence for a protective (synergistic?)
effect of B-vitamins and omega–3 fatty acids on cardiovascular diseases. EJCN,
58 (5), 732–744. URL: http://www.nature.com/ejcn/journal/v58/n5/full/1601871a.html
(accessed 12.14.2006).
Geleijnse, J., et al. 2002. Blood pressure response to fish oil
supplementation: Metaregression analysis of randomized trials. J. Hypertens., 20
(8), 1493–1499.
Curtis, C., et al. 2000. n-3 Fatty acids specifically modulate
catabolic factors involved in articular cartilage degradation. J. Biol. Chem.
275, 721–724.
2 Geerts, S., et al. 2002. Systemic release of endotoxins induced by
gentle mastication: association with periodontitis severity. J. Periodontology,
73 (1) 73–78; URL: American Academy of Periodontology: http://www.perio.org/consumer/bacteria.htm (accessed 01.04.06).
3 Chiang, N., et al. 2005. Aspirin has a gender-dependent impact on antiinflammatory
15-epi-lipoxin A4 formation. A randomized human trial. Arterioscler. Thromb. Vasc.
Biol. Nov 17; [Epub ahead of print].
Ridker, P., et al. 2005. A randomized trial of low-dose aspirin
in the primary prevention of cardiovascular disease in women. NEJM, 352
(13), 1293–1304.
Further reading
Bazzano, C., et al. 2006. Effect of folic acid supplementation on risk of cardiovascular
diseases. JAMA, 296 (22), 2720–2726.
Return to:
Heart disease risk factors
Last Modified Date: 05/02/2011